The International Atherosclerosis Society (IAS) and Pfizer are collaborating to offer a new grant opportunity focused on improving care for patients with medium or high levels of cardiovascular risk, with a particular focus on dyslipidemia.
This RFP is being issued by both organizations. The IAS is the lead organization for review and evaluation of applications. A review committee, led by the IAS, will make decisions on which proposals will receive funding. Grant funding will be provided by Pfizer. Collectively, up to $2 million is available for winning projects.
Click here to read the full RFP. Letters of intent are due Oct. 31, 2013 and applicants will be invited via email by Dec. 2 to submit a full proposal, which will be due Jan. 30, 2014. Please contact the IAS at RFP@athero.org, for further information.
For more funding opportunities, visit the Duke Funding Opportunities database.